Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y017511 | OT / LL |
No additional AEs; Vaccine administered after temperature excursion; This spontaneous report was received from a Physician and refers to a 4-year-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included Diphtheria vaccine toxoid (+) Pertussis vaccine acellular (+) Tetanus vaccine toxoid (DTAP), and Polio vaccine inact (IPV). On 11-MAR-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), dose number 2, administered by Subcutaneous route in Left Thigh as prophylaxis (lot number Y017511 has been verified to be valid for Measles, Mumps, Rubella and Varicella [Oka-Merck] Virus Vaccine Live [PROQUAD], expiration date 15-APR-2026), which was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot number and expiration date was not provided). The dose was administered after a temperature excursion (TE) that occurred at -9.8 degree Celsius (C) for 2 hours and 3 minutes, with no previous temperature excursion. No additional adverse event was reported for the patient.
DTAP; IPV; Sterile diluent